glp-1 and dual glp-1/gip receptor agonists The Sustained Effects of a GIP/GLP-1 Agonist, NNC0090-2746, in Patients with Type 2 Diabetes The dual glucose-dependent insulinotropic polypeptide

Glutamate is released at synapses throughout the brain, and exerts changes in postsynaptic excitability and neuroplasticity (68)

95% Curcumin

Each patient needs to adhere to a customized plan

Regular physical activity, which provides stress-reducing effects through multiple mechanisms

Benefits: Chronic illness or infections Oxidative stress Antioxidant Cell / tissue repair & regeneration Immune system support *Some blood testing may be required

Current treatment options for PACS still primarily emphasize managing the symptoms but neglect the underlying cause, such as persistent inflammation, immune dysfunction, and tissue damage